Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1982 1
1983 3
1984 1
1985 5
1986 1
1987 3
1988 9
1989 2
1990 11
1991 7
1992 4
1993 4
1994 1
1995 9
1996 7
1997 6
1998 12
1999 7
2000 6
2001 7
2002 4
2003 5
2004 3
2005 7
2006 9
2007 9
2008 4
2009 13
2010 15
2011 7
2012 7
2013 4
2014 5
2015 6
2016 2
2017 1
2018 1
2019 3
2020 2
2021 5
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F, Voorhees P, Dispenzieri A, Fosså A, Srkalovic G, Ide M, Munshi N, Schey S, Streetly M, Pierson SK, Partridge HL, Mukherjee S, Shilling D, Stone K, Greenway A, Ruth J, Lechowicz MJ, Chandrakasan S, Jayanthan R, Jaffe ES, Leitch H, Pemmaraju N, Chadburn A, Lim MS, Elenitoba-Johnson KS, Krymskaya V, Goodman A, Hoffmann C, Zinzani PL, Ferrero S, Terriou L, Sato Y, Simpson D, Wong R, Rossi JF, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Oksenhendler E, Fajgenbaum DC. van Rhee F, et al. Among authors: rossi jf. Blood. 2018 Nov 15;132(20):2115-2124. doi: 10.1182/blood-2018-07-862334. Epub 2018 Sep 4. Blood. 2018. PMID: 30181172 Free PMC article.
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS. Fajgenbaum DC, et al. Among authors: rossi jf. Blood. 2017 Mar 23;129(12):1646-1657. doi: 10.1182/blood-2016-10-746933. Epub 2017 Jan 13. Blood. 2017. PMID: 28087540 Free PMC article.
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.
van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C. van Rhee F, et al. Among authors: rossi jf. Lancet Oncol. 2014 Aug;15(9):966-74. doi: 10.1016/S1470-2045(14)70319-5. Epub 2014 Jul 17. Lancet Oncol. 2014. PMID: 25042199 Clinical Trial.
Interleukin-6 as a therapeutic target.
Rossi JF, Lu ZY, Jourdan M, Klein B. Rossi JF, et al. Clin Cancer Res. 2015 Mar 15;21(6):1248-57. doi: 10.1158/1078-0432.CCR-14-2291. Epub 2015 Jan 14. Clin Cancer Res. 2015. PMID: 25589616 Review.
Targeted Therapies in Adult B-Cell Malignancies.
Rossi JF. Rossi JF. Biomed Res Int. 2015;2015:217593. doi: 10.1155/2015/217593. Epub 2015 Sep 6. Biomed Res Int. 2015. PMID: 26425544 Free PMC article. Review.
Tocilizumab in Treatment for Patients With COVID-19.
Rossi JF, Chiang HC, Klein B. Rossi JF, et al. JAMA Intern Med. 2021 Jul 1;181(7):1018-1019. doi: 10.1001/jamainternmed.2021.0395. JAMA Intern Med. 2021. PMID: 33818612 No abstract available.
Activation molecules on human myeloma cells.
Klein B, Li XY, Lu ZY, Jourdan M, Tarte K, Brochier J, Claret E, Wijdenes J, Rossi JF. Klein B, et al. Among authors: rossi jf. Curr Top Microbiol Immunol. 1999;246:335-41. doi: 10.1007/978-3-642-60162-0_41. Curr Top Microbiol Immunol. 1999. PMID: 10396073 Review. No abstract available.
[Therapeutic monoclonal antibodies in onco-hematology].
Cartron G, Rossi JF. Cartron G, et al. Among authors: rossi jf. Med Sci (Paris). 2009 Dec;25(12):1085-9. doi: 10.1051/medsci/200925121085. Med Sci (Paris). 2009. PMID: 20035683 Free article. Review. French.
Rituximab-induced vasculitis.
Dereure O, Navarro R, Rossi JF, Guilhou JJ. Dereure O, et al. Among authors: rossi jf. Dermatology. 2001;203(1):83-4. doi: 10.1159/000051713. Dermatology. 2001. PMID: 11549810 No abstract available.
210 results